Abstract

Neurodevelopmental disorders are a group of complex multifactorial disorders with significant overlapping of symptoms that arise during the developmental period. This article looks into changing perspectives and evolving knowledge of these disorders as well as their future directions. These disorders can not only affect individuals but society as a whole. Accumulated knowledge of these disorders slowly began to change the perception of the disorders as well as how individuals experiencing these conditions are treated by society.

Keywords: Neurodevelopmental Disorders; Electro Encephalogram; Low Birth Weight

References

1. Mullin AP., et al. “Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes”. Translational Psychiatry12 (2013): e329.
2. ICD-11, International Classification of Diseases 11th Revision. The global standard for diagnostic health information (2018).
3. Diagnostic and Statistical Manual of Mental Disorders. 5th ed.: The American Psychiatric Association (APA) (2013).
4. Harris JC. “New terminology for mental retardation in DSM-5 and ICD-11”. Current Opinion in Psychiatry 3 (2013): 260-262.
5. Casey BJ., et al. “A Neurodevelopmental Perspective on the Research Domain Criteria (RDoC) Framework”. Biological Psychiatry5 (2014): 350-353.
6. Morris-Rosendahl DJ and Crocq M. “Neurodevelopmental disorders—the history and future of a diagnostic concept”. Dialogues in Clinical Neuroscience1 (2020): 65-72.
7. Gaudet I and Gallagher A. “Description and classification of neurodevelopmental disabilities”. Handbook of Clinical Neurology: Elsevier Health Sciences (2020): 3-6.
8. Wehmeyer M. ‘The Story of Intellectual Disability: An Evolution of Meaning, Understanding, and Public perception”- Book, Baltimore: Paul H. Brookes Publishing Co (2013).
9. Groff CA. “Mental retardation”. New York, NY: MSS Information Corporation (1973).
10. McNabb C. Medieval Disability Sourcebook: Western Europe. Punctum Books (2020).
11. Ivan Brown and John P Radford. “The Growth and Decline of Institutions for People with Developmental Disabilities in Ontario: 1876-2009”. Journal on Developmental Disabilities2 (2015): 7.
12. Children's Health and the Environment WHO Training Package for the Health Sector World Health Organization. CHILDREN ANDNEURODEVELOPMENTAL BEHAVIOURAL. INTELLECTUAL DISORDERS (NDBID).
13. Vissers Lisenka ELM., et al. “Genetic studies in intellectual disability and related disorders”. Nature Reviews Genetics 1 (2015): 9-18.
14. Mitchell KJ. “The Genetic Architecture of Neurodevelopmental Disorders”. The Genetics of Neurodevelopmental Disorders Hoboken, NJ, USA: John Wiley and Sons, Inc (2015): 1-28.
15. Moore KL. “Theœ developing human”. Philadelphia [u.a.]: Saunders (1973).
16. Hendren R and Hagerman R. “Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms: Targeting Neurobiological Mechanisms”. Oxford University Press (2014).
17. Rice D., et al. “Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models”. Environmental Health Perspectives 108 (2000): 511-533.
18. Schuengel C., et al. “Impact of Research About the Early Development of Children With Intellectual Disability: A Science Mapping Analysis”. Frontiers in Education (Lausanne) 4 (2019): 1-11.
19. “Diagnosis of Birth Defects”.
20. Bélanger SA and Caron J. “Evaluation of the child with global developmental delay and intellectual disability”. Paediatrics and Child Health6 (2018): 403-410.
21. Wieacker P and Steinhard J. “The prenatal diagnosis of genetic diseases”. Deutsches Ärzteblatt International48 (2010): 857-862.
22. Understanding Genetics: A District of Columbia Guide for Patients and Health Professionals Genetic Alliance, District of Columbia Department of Health Genetic Alliance, Posted in the Resource Repository (2010).
23. van Karnebeek CD and Stockler-Ipsiroglu S. “Early identification of treatable inborn errors of metabolism in children with intellectual disability: the treatable intellectual disability endeavor protocol in British Columbia”. Paediatrics and Child Health9 (2014): 469-471.
24. Sun F., et al. “Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder” (2015).
25. Shaffer LG. “American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation”. Genetics in Medicine9 (2005): 650-654.
26. Moore P. “Autism and Other Neurodevelopmental Disorders”. R.L. Hansen and S.J. Rogers (Eds.) Washington, DC: American Psychiatric Association (2013): 326.
27. Picker JD and Walsh CA. “New innovations: Therapeutic opportunities for intellectual disabilities”. Annals of Neurology3 (2013): 382-390.
28. Bauman ML БМЛ. “Autism: Multidisciplinary Evaluation and Treatment. The LADDERS Model”. Autism and Developmental Disorders3 (2020): 22.
29. Hendren RL., et al. “Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism”. Journal of Child and Adolescent Psychopharmacology9 (2016): 774-783.
30. Michael Telias Dalit Ben-Yosef. “Neural stem cell replacement： a possible therapy for neurodevelopmental disorders”. Neural Regeneration Research2 (2015): 180-182.
31. Cheffer A., et al. “Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction”. Molecular Autism1 (2020): 99.
32. Gray SJ. “Gene therapy and neurodevelopmental disorders”. Neuropharmacology 68 (2013): 136-142.
33. Turner TJ., et al. “Recent advances in gene therapy for neurodevelopmental disorders with epilepsy”. Journal of Neurochemistry (2020).
34. Wu H., et al. “Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model”. International Journal of Molecular Sciences9 (2018): 2840.
35. Datko M., et al. “Positive effects of neurofeedback on autism symptoms correlate with brain activation during imitation and observation”. The European Journal of Neuroscience6 (2018): 579-591.
36. HOLTMANN M., et al. “Neurofeedback in autism spectrum disorders”. Developmental Medicine and Child Neurology11 (2011): 986-993.
37. McGuinness G and Kim Y. “Sulforaphane treatment for autism spectrum disorder: A systematic review”. (2020).

Citation

Citation: Prajjita Bardoloi. “Neurodevelopmental Disorders: The Past, Present and the Future”. Acta Scientific Neurology 4.2 (2021): 44-50.

Copyright

Copyright: © 2021 Prajjita Bardoloi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.